C3.ai Edges UiPath as Better AI Investment Despite UiPath's Valuation Appeal

The artificial intelligence software market is expanding fast—forecasters expect it to nearly triple from $242 billion in 2023 to $739 billion by 2030, a compound annual growth rate of 17 percent. Two companies positioned to capture that growth are UiPath and C3.ai, both of which sell automation software that helps businesses streamline operations. Yet choosing between them requires weighing very different risk profiles and trajectories.

UiPath builds tools that handle routine corporate tasks: scanning loan applications for missing information, fielding customer emails, automating the kind of work that consumes hours of human attention. The company had been growing steadily until recently. In its fiscal first quarter ending April 30, it posted $335 million in revenue, up 16 percent year-over-year. Then in late May, the company announced its CEO had resigned and slashed its full-year revenue guidance from $1.6 billion down to $1.4 billion, citing a sudden slowdown in sales execution. The co-founder and former CEO, Daniel Dines, returned to lead the company, bringing some stability to a moment of visible turbulence. Despite the sales stumble, UiPath's underlying finances remain sturdy. The company generated $101.3 million in free cash flow in the quarter, a 40 percent improvement from the year before. Its balance sheet shows $2.8 billion in total assets against only $818 million in liabilities, with no debt. The company is narrowing its losses—a net loss of $28.7 million in Q1, down from $31.9 million the prior year—and moving toward profitability.

C3.ai took a different path to the same destination. The company evolved from an energy management and Internet of Things specialist into an AI platform business. Its software lets customers adopt artificial intelligence without building the infrastructure from scratch. Shell, for instance, uses C3.ai's platform to predict equipment failures before they happen, catching maintenance needs proactively. In its fiscal year ended April 30, C3.ai generated $310.6 million in revenue, also up 16 percent year-over-year. The company projects fiscal 2025 revenue will reach at least $370 million, a 23 percent increase. C3.ai's balance sheet is solid—$1 billion in assets versus $165 million in liabilities. But profitability remains elusive. The company posted a net loss of $72.9 million in its fiscal fourth quarter, worse than the prior year's $65 million loss. More concerning, C3.ai's operating cash flow turned negative, at minus $62.4 million in Q4. For a fast-growing tech company, operating at a loss is not unusual, but investors will want to see the company move toward profitability as it matures.

When comparing the two, valuation becomes a key lens. Neither company is profitable, so traditional price-to-earnings ratios don't apply. Using price-to-sales ratios instead, UiPath looks cheaper after its stock price fell on the CEO resignation news and guidance cut. That lower valuation could mean significant upside if UiPath successfully restores its sales momentum. C3.ai, by contrast, shows clearer near-term growth momentum. Its fiscal 2025 guidance suggests revenue will accelerate, and the company has demonstrated it can execute on that kind of expansion. The trade-off is straightforward: UiPath offers better value but carries more uncertainty about whether its sales rebound will materialize. C3.ai commands a higher price but offers more predictable growth in the quarters ahead. For investors prioritizing a visible growth trajectory over a bargain entry point, C3.ai edges ahead. For those with higher risk tolerance and patience to wait and see whether UiPath's sales challenges prove temporary, the cheaper valuation may eventually reward that bet.